156 related articles for article (PubMed ID: 37308819)
1. Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13).
Kaboré NF; Ouédraogo S; Mamguem AK; Traoré IT; Kania D; Badolo H; Sanou G; Koné A; Yara M; Kagoné T; Ouédraogo E; Konaté B; Médah R; de Rekeneire N; Poda A; Diendéré AE; Ouédraogo B; Billa O; Paradis G; Dabakuyo-Yonli TS; Tinto H
BMC Infect Dis; 2023 Jun; 23(1):394. PubMed ID: 37308819
[TBL] [Abstract][Full Text] [Related]
2. The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population-based, age-stratified sero-epidemiological investigation.
Ouedraogo S; Traoré IT; Kania D; Kaboré NF; Mamguem Kamga A; Badolo H; Yara M; Sanou G; Koné A; Kagoné ST; Ouédraogo E; Konaté B; Médah R; de Rekeneire N; Poda A; Diendere AE; Ouédraogo B; Billa O; Paradis G; Tinto H; Dabakuyo-Yonli TS
Influenza Other Respir Viruses; 2023 Nov; 17(11):e13216. PubMed ID: 38019697
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 epidemiological, sociological and anthropological investigation: study protocol for a multidisciplinary mixed methods research in Burkina Faso.
Traoré IT; Ouedraogo S; Kania D; Kaboré FN; Konaté B; Médah R; Badolo H; de Rekeneire N; Kamga AM; Poda A; Diendere AE; Ouédraogo B; Ouédraogo E; Billa O; Tinto H; Dabakuyo-Yonli TS
BMC Infect Dis; 2021 Sep; 21(1):896. PubMed ID: 34479501
[TBL] [Abstract][Full Text] [Related]
4. Seroepidemiology of syphilis among men who have sex with men in Burkina Faso, West Africa.
Ouedraogo HG; Zida S; Compaore TR; Lanou BH; Rao A; Sagna T; Kadari C; Tarnagda G; Ky-Zerbo O; Traore Y; Baral S; Kouanda S; Barro N
Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1803-1809. PubMed ID: 31201641
[TBL] [Abstract][Full Text] [Related]
5. High seroprevalence of SARS-CoV-2 in Burkina-Faso, Ghana and Madagascar in 2021: a population-based study.
Struck NS; Lorenz E; Deschermeier C; Eibach D; Kettenbeil J; Loag W; Brieger SA; Ginsbach AM; Obirikorang C; Maiga-Ascofare O; Sarkodie YA; Boham EEA; Adu EA; Asare G; Amoako-Adusei A; Yawson A; Boakye AO; Deke J; Almoustapha NS; Adu-Amoah L; Duah IK; Ouedraogo TA; Boudo V; Rushton B; Ehmen C; Fusco D; Gunga L; Benke D; Höppner Y; Rasolojaona ZT; Rasamoelina T; Rakotoarivelo RA; Rakotozandrindrainy R; Coulibaly B; Sié A; Awuah AA; Amuasi JH; Souares A; May J
BMC Public Health; 2022 Sep; 22(1):1676. PubMed ID: 36064368
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus (HIV) among men who have sex with men: results of the first integrated biological and behavioral survey in Burkina Faso, West Africa.
Ouedraogo HG; Ky-Zerbo O; Grosso A; Goodman S; Samadoulougou BC; Tarnagda G; Baguiya A; Tiendrebeogo S; Lougue M; Sawadogo N; Traore Y; Barro N; Baral S; Kouanda S
BMC Public Health; 2019 Jan; 19(1):5. PubMed ID: 30606172
[TBL] [Abstract][Full Text] [Related]
7. Structural determinants of health among women who started selling sex as minors in Burkina Faso.
Grosso AL; Ketende S; Dam K; Papworth E; Ouedraogo HG; Ky-Zerbo O; Baral S
J Acquir Immune Defic Syndr; 2015 Mar; 68 Suppl 2():S162-70. PubMed ID: 25723981
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Predictors of Imported Cases of COVID-19 in Burkina Faso.
Kaboré M; Sondo KA; Dahourou DL; Cissoko Y; Konaté I; Zaré A; Bicaba B; Ouedraogo B; Barro H; Diendéré EA; Asamoah I; Damoue SN; Siri BAA; Diallo I; Puplampu P; Poda AG; Toloba Y; Dao S; Ouédraogo M; Kouanda S
Front Public Health; 2022; 10():743248. PubMed ID: 35252079
[TBL] [Abstract][Full Text] [Related]
9. Monitoring Insecticide Susceptibility in
Namountougou M; Soma DD; Balboné M; Kaboré DA; Kientega M; Hien A; Coulibaly A; Ouattara PE; Meda BG; Drabo S; Koala L; Nignan C; Kagoné T; Diabaté A; Fournet F; Gnankiné O; Dabiré RK
Trop Med Infect Dis; 2020 May; 5(2):. PubMed ID: 32471266
[TBL] [Abstract][Full Text] [Related]
10. Clinical management and mortality among COVID-19 cases in sub-Saharan Africa: A retrospective study from Burkina Faso and simulated case analysis.
Skrip L; Derra K; Kaboré M; Noori N; Gansané A; Valéa I; Tinto H; Brice BW; Gordon MV; Hagedorn B; Hien H; Althouse BM; Wenger EA; Ouédraogo AL
Int J Infect Dis; 2020 Dec; 101():194-200. PubMed ID: 32987177
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of ten (10) SARS-CoV-2 rapid serological tests in comparison with WANTAI SARS-CoV-2 ab ELISA in Burkina Faso, West Africa.
Ouedraogo HG; Zoure AA; Compaoré TR; Ky H; Zida S; Zingué D; Ouedraogo O; Soubeiga ST; Sagna T; Dabiré C; Kambiré D; Zongo D; Yonli AT; Nikiema AR; Nezien D; Bansé GC; Bicaba BW; Perier S; Sawadogo C; Yabre Z; Sangare L
Virol J; 2023 Mar; 20(1):57. PubMed ID: 36997951
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of SARS-CoV-2 in urban settings in three sub-Saharan African countries (SeroCoV): a study protocol for a household-based cross-sectional prevalence study using two-stage cluster sampling.
Lorenz E; Souares A; Amuasi J; Loag W; Deschermeier C; Fusco D; Benke D; A Rakotoarivelo R; Rasamoelina MT; Rakotozandrindrainy R; Sie A; Afum-Adjei Awuah A; May J; Eibach D; Struck N
BMJ Open; 2021 Dec; 11(12):e056853. PubMed ID: 34921091
[TBL] [Abstract][Full Text] [Related]
13. High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.
Lalwani P; Araujo-Castillo RV; Ganoza CA; Salgado BB; Pereira Filho IV; da Silva DSS; de Morais TBDN; Jordão MF; Ortiz JV; Barbosa ARC; Sobrinho WBS; Cordeiro IB; de Souza Neto JN; de Assunção EN; da Costa CF; de Souza PE; de Albuquerque BC; Astofi-Filho S; ; Lalwani JDB
Lancet Glob Health; 2021 Nov; 9(11):e1508-e1516. PubMed ID: 34678195
[TBL] [Abstract][Full Text] [Related]
14. HIV infection among pregnant women in Bobo-Dioulasso, Burkina Faso: comparison of voluntary and blinded seroprevalence estimates.
Meda N; Zoundi-Guigui MT; van de Perre P; Alary M; Ouangré A; Cartoux M; Mandelbrot L; Viens P; Dabis F
Int J STD AIDS; 1999 Nov; 10(11):738-40. PubMed ID: 10563562
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the impact of COVID-19 in people coinfected with HIV and/or tuberculosis in low-income countries: study protocol for mixed methods research in Burkina Faso.
Ouattara CA; Poda AG; Méda ZC; Sawadogo Y; Kabore O; Birba E; Sourabié A; Zoungrana J; Traore IT; Sangaré I; Ymba A; Godreuil S; Ouedraogo AS
BMC Infect Dis; 2023 Feb; 23(1):108. PubMed ID: 36814211
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.
Letizia AG; Ge Y; Vangeti S; Goforth C; Weir DL; Kuzmina NA; Balinsky CA; Chen HW; Ewing D; Soares-Schanoski A; George MC; Graham WD; Jones F; Bharaj P; Lizewski RA; Lizewski SE; Marayag J; Marjanovic N; Miller CM; Mofsowitz S; Nair VD; Nunez E; Parent DM; Porter CK; Santa Ana E; Schilling M; Stadlbauer D; Sugiharto VA; Termini M; Sun P; Tracy RP; Krammer F; Bukreyev A; Ramos I; Sealfon SC
Lancet Respir Med; 2021 Jul; 9(7):712-720. PubMed ID: 33865504
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
18. Development of a spatial sampling protocol using GIS to measure health disparities in Bobo-Dioulasso, Burkina Faso, a medium-sized African city.
Kassié D; Roudot A; Dessay N; Piermay JL; Salem G; Fournet F
Int J Health Geogr; 2017 Apr; 16(1):14. PubMed ID: 28420404
[TBL] [Abstract][Full Text] [Related]
19. HIV among Female Sex Workers in Five Cities in Burkina Faso: A Cross-Sectional Baseline Survey to Inform HIV/AIDS Programs.
Ouedraogo HG; Ky-Zerbo O; Baguiya A; Grosso A; Goodman S; Samadoulougou BC; Lougue M; Sawadogo N; Traore Y; Barro N; Baral S; Kouanda S
AIDS Res Treat; 2017; 2017():9580548. PubMed ID: 29270318
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy rate and birth outcomes among women receiving antiretroviral therapy in Burkina Faso: a retrospective cohort study.
Poda A; Hema A; Konaté A; Kaboré F; Zoungrana J; Kamboulé E; Soré I; Bado G; Ouédraogo AS; Ouédraogo M; Meda N; Sawadogo AB
Pan Afr Med J; 2016; 23():105. PubMed ID: 27222692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
